References
- Reus VI: Rational polypharmacy in the treatment of mood disorders. Ann Clin Psychiatry 1993; 5(2):91–100
- Golden RN, Rudorfer MV, Sherer MA, et al.: Bupropion in depression: Biochemical effects and clinical response. Arch Gen Psychiatry 1988; 45:139–143
- Ferris RM, Cooper BR: Mechanism of antidepressant activity of bupropion. J Clin Psychiatry (Monogr Ser) 1993; 11(1):2–14
- Zung W: Review of placebo-controlled trials with bupropion. J Clin Psychiatry 1983; 45(2):104–114
- Zisock S: Efficacy of bupropion. J Clin Psychiatry (Monogr Ser) 1993; 11(1):20–29
- Settle EC: Bupropion: General side effects. J Clin Psychiatry (Monogr Ser) 1993; 11(1):33–39
- Apter JT, Woolfolk R: Lithium augmentation of bupropion in refractory depression. Ann Clin Psychiatry 1990; 2:7–10
- Novae A: Fluoxetine and bupropion treatment of bipolar dis-order, type II, associated with generalized anxiety disorder. J Clin Psychiatry 1992; 53(2):67
- Sulser F: Functional aspects of the norepinephrine receptor coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate de-pression: Molecular approaches to an understanding of af-fective disorders. Pharmakopsychiatr Neuropsychopharmakol 1978; 11:43–52
- Sulser F, Vetulani J, Mobley PL: Mode of action of antide-pressant drugs. Biochem Pharmacol 1978; 27:257–261